FY2024 EPS Estimate for Ascend Wellness Decreased by Analyst

Ascend Wellness Holdings, Inc. (OTC:AAWH) – Research analysts at Cormark dropped their FY2024 earnings per share (EPS) estimates for shares of Ascend Wellness in a research note issued to investors on Wednesday, November 13th. Cormark analyst J. Pytlak now expects that the company will post earnings per share of ($0.41) for the year, down from their prior forecast of ($0.35). The consensus estimate for Ascend Wellness’ current full-year earnings is ($0.32) per share. Cormark also issued estimates for Ascend Wellness’ FY2025 earnings at ($0.23) EPS.

Ascend Wellness (OTC:AAWH) last released its earnings results on Tuesday, November 12th. The company reported ($0.13) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.03). The firm had revenue of $141.65 million for the quarter, compared to the consensus estimate of $144.13 million. Ascend Wellness had a negative return on equity of 66.28% and a negative net margin of 15.47%.

Ascend Wellness Price Performance

AAWH opened at $0.50 on Friday. The company has a fifty day moving average price of $0.83 and a two-hundred day moving average price of $0.96. The firm has a market capitalization of $106.95 million, a PE ratio of -1.22 and a beta of 1.69. Ascend Wellness has a 52 week low of $0.45 and a 52 week high of $1.82. The company has a debt-to-equity ratio of 2.46, a quick ratio of 1.29 and a current ratio of 2.29.

About Ascend Wellness

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.